Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris

New weapons to fight a new enemy: A systematic review of drug combinations against the drug‐resistant fungus Candida auris

(2021) Sanaz Aghaei Gharehbolagh et al.   MYCOSES

Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era

(2021) Liming Lin et al.   Acta Pharmaceutica Sinica B

Retinoids in Fungal Infections: From Bench to Bedside

(2021) Terenzio Cosio et al.   Pharmaceuticals

Predictive role of vitamin A serum concentration in psoriatic patients treated with IL-17 inhibitors to prevent skin and systemic fungal infections

(2020) Elena Campione et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Invasive Fungal Infections and Their Epidemiology: Measures in the Clinical Scenario

(2019) Vivek K. Bajpai et al.   BIOTECHNOLOGY AND BIOPROCESS ENGINEERING

The Synergistic Antifungal Effect and Potential Mechanism of D-Penicillamine Combined With Fluconazole Against Candida albicans

(2019) Yiman Li et al.   Frontiers in Microbiology

Cell permeability and nuclear DNA staining by propidium iodide in basidiomycetous yeasts

(2018) Ning Zhang et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Candida auris : an Emerging Fungal Pathogen

(2017) Emily S. Spivak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antifungal activity of ionic liquids based on (−)-menthol: a mechanism study

(2017) Jakub Suchodolski et al.   MICROBIOLOGICAL RESEARCH

In Vitro Antifungal Activity of (1)-N-2-Methoxybenzyl-1,10-phenanthrolinium Bromide against Candida albicans and Its Effects on Membrane Integrity

(2017) Setiawati Setiawati et al.   MYCOBIOLOGY

Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38

(2017) Vivek K. Bajpai et al.   Scientific Reports

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

The Phylogeny and Active Site Design of Eukaryotic Copper-only Superoxide Dismutases

(2016) Ryan L. Peterson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Partially Purified Exo-Polysaccharide fromLactobacillus SakeiProbio 65 with Antioxidant, α-Glucosidase and Tyrosinase Inhibitory Potential

(2016) Vivek K. Bajpai et al.   JOURNAL OF FOOD BIOCHEMISTRY

First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia

(2016) Belinda Calvo et al.   JOURNAL OF INFECTION

Combinatorial strategies for combating invasive fungal infections

(2016) Michaela Spitzer et al.   Virulence

Antimicrobial Peptides: An Emerging Category of Therapeutic Agents

(2016) Margit Mahlapuu et al.   Frontiers in Cellular and Infection Microbiology

Effect of two monoterpene phenols on antioxidant defense system in Candida albicans

(2015) Amber Khan et al.   MICROBIAL PATHOGENESIS

Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections

(2015) Michele Scarsini et al.   PEPTIDES

Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans

(2015) Aijaz Ahmad et al.   PLoS One

LL-37-Derived Peptides Eradicate Multidrug-Resistant Staphylococcus aureus from Thermally Wounded Human Skin Equivalents

(2014) Elisabeth M. Haisma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide

(2014) M. Garcia-Quintanilla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence, characteristics and outcome of ICU-acquired candidemia in India

(2014) Arunaloke Chakrabarti et al.   INTENSIVE CARE MEDICINE

Responses of Candida albicans to the human antimicrobial peptide LL-37

(2014) Pei-Wen Tsai et al.   JOURNAL OF MICROBIOLOGY

Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin

(2014) Bruno Maras et al.   PLoS One

Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial

(2014) Alvar Grönberg et al.   WOUND REPAIR AND REGENERATION

Mechanisms Underlying the Exquisite Sensitivity of Candida albicans to Combinatorial Cationic and Oxidative Stress That Enhances the Potent Fungicidal Activity of Phagocytes

(2014) D. Kaloriti et al.   mBio

Biomarkers of lipid peroxidation in clinical material

(2013) Etsuo Niki   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection

(2013) D. M. MacCallum et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain

(2013) M. Bassetti et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

(2010) Robert Bucki et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Effect of diallyldisulphide on an antioxidant enzyme system in Candida species

(2010) Snowber Yousuf et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids

(2010) Amber Khan et al.   FEMS YEAST RESEARCH

Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections

(2010) K. Leszczyńska et al.   JOURNAL OF APPLIED MICROBIOLOGY

Human defensins and LL-37 in mucosal immunity

(2009) Mona Doss et al.   JOURNAL OF LEUKOCYTE BIOLOGY